Specialities

Neurology

Lege Artis Medicinae

MARCH 31, 2022

[Clinical implication of arterial stiffness in the elderly]

BENCZÚR Béla

[Hypertension prevalence and cardiovascular risk gradually with age. However this aging process seems to take a more rapid course in some individuals, as reflected in the Early Vascular Aging (EVA) syndrome. Age and high blood pressure are the two main determinants of arterial stiffness which is the core of EVA: the impaired elasticity of the media layer of large elastic arteries (mainly the aorta), a process that can be measured by pulse wave velocity. In elderly hyperten­sives, large arteries... tovább »

Lege Artis Medicinae

MARCH 31, 2022

[Whether we teach effectively what we consider being important? As seen by medical educators]

VARGA Zsuzsanna, PÓTÓ Zsuzsanna, CSATHÓ Árpád, FÜZESI Zsuzsanna

[In Hungary the training and output requirements of faculty of general medicine determine the required knowledge, skills and abilities, i.e. competences of graduated me­dical doctors. On the one hand, we examined how the tea­chers ponder the weight of competences established for medical education in the training and output requirements, on the other hand to what extent they mediate these during their teaching activity. The field research by self-developed questionnaires was carried out in... tovább »

Clinical Neuroscience

MARCH 31, 2022

[How our view of epileptogenesis and mechanism of epilepsy changes? The system epilepsies’ concept]

HALÁSZ Péter, SZÛCS Anna

[To examine the ways of epileptogenesis closely linked to the system epilepsies’ concept. We follow the ways of epileptic transformation in the declarative memory-system, in the sleep/arousal twin-systems, in the perisylvian neuronal network and in postinjury epilepsy, which we consider a general model of the epileptic transformation. In the presented systems, epileptogenesis shares a similar mechanism in the form of augmentation and derailment of plasticity and sleep-related synaptic... tovább »

Clinical Neuroscience

MARCH 31, 2022

How does the use of antiplatelet and anticoagulants affect the success of mechanical thrombectomy in acute ischemic stroke cases?

ÇABALAR Murat , ŞENGEZE Nihat , EREN Alper , İNANÇ Yusuf , GİRAY Semih

In this study, we wanted to investigate the effect of antiplatelet and anticoagulant use on the success of mechanical thrombectomy in acute ischemic stroke cases. 174 patients who were brought to the Stroke Center of Gaziantep University Şahinbey Research and Practice Hospital between January 2018 and February 2019 due to acute ischemic stroke and who underwent mechanical thrombectomy were retrospectively analyzed. The demographic characteristics, antiplatelet/anticoagulant use before the... tovább »

Clinical Neuroscience

MARCH 31, 2022

[New, innovative prognosis calculator for patients with metastatic spinal tumors]

MEZEI Tamás, BÁSKAY János, POLLNER Péter , HORVÁTH Anna, NAGY Zoltán , CZIGLÉCZKI Gábor , BANCZEROWSKI Péter

[The aim of our research was to create a scoring system that predicts prognosis and recommends therapeutic options for patients with metastatic spine tumor. Increasing oncological treatment opportunities and prolonged survival have led to a growing need to address clinical symptoms caused by meta­stases of the primary tumor. Spinal metastases can cause a significant reduction in quality of life due to the caused neurological deficits. A scoring system that predicts prognosis with sufficient... tovább »

Clinical Neuroscience

MARCH 31, 2022

Lymphopenia and tuberculous lymphadenitis under immunomodulatory agents in a multiple sclerosis patient: Follow-up of a challenging case

KOSEAHMET Basoglu Fulya, OZTURK Musa , CELIK R. Gokcen Gozubatik

Interferon-beta (IFN-β) 1a and glatiramer acetate (GA) are first-line therapies for multiple sclerosis (MS) with immunomodulatory effects. We present a patient who developed lymphopenia and tuberculous lymphadenitis under treatment with these agents. The female patient who at present 65 year old is followed at our MS outpatient clinics had received GA (20 mg/day, subcutaneous injection) and later IFN-β 1a (44 µg, thrice weekly, subcutaneous injection). During the course of her treatment, she... tovább »